Clinical Trials Directory

Trials / Unknown

UnknownNCT04992455

G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients

The Predictive Value of G8, VES-13 and CARG Scores in Treatment-related Toxicity in Geriatric Cancer Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Namik Kemal University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. The suitability of G8, VES-13 and CARG chemotherapy risk assessment tools for elderly cancer patients was investigated.

Detailed description

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. G8, VES-13 and CARG toxicity scores of all participating patients will be determined by two independent investigators before starting chemotherapy. The suitability of these practical chemotherapy risk assessment tools for cancer patients for elderly cancer patients was investigated.

Conditions

Interventions

TypeNameDescription
OTHEROlder Patients Receiving ChemotherapyNo Intervention

Timeline

Start date
2021-02-01
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2021-08-05
Last updated
2021-08-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04992455. Inclusion in this directory is not an endorsement.